ATE279924T1 - 3-cyclopropylmethoxy-4-difluormethoxy-n-(3,5- dichlor-pyrid-4-yl)-benzamid zur behandlung von multipler sklerose - Google Patents

3-cyclopropylmethoxy-4-difluormethoxy-n-(3,5- dichlor-pyrid-4-yl)-benzamid zur behandlung von multipler sklerose

Info

Publication number
ATE279924T1
ATE279924T1 AT00910736T AT00910736T ATE279924T1 AT E279924 T1 ATE279924 T1 AT E279924T1 AT 00910736 T AT00910736 T AT 00910736T AT 00910736 T AT00910736 T AT 00910736T AT E279924 T1 ATE279924 T1 AT E279924T1
Authority
AT
Austria
Prior art keywords
cyclopropylmethoxy
difluoromethoxy
benzamide
treatment
multiple sclerosis
Prior art date
Application number
AT00910736T
Other languages
German (de)
English (en)
Inventor
Hermann Amschler
Armin Hatzelmann
Christian Schudt
Hans-Peter Kley
Karl Sanders
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE279924T1 publication Critical patent/ATE279924T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT00910736T 1999-03-10 2000-03-01 3-cyclopropylmethoxy-4-difluormethoxy-n-(3,5- dichlor-pyrid-4-yl)-benzamid zur behandlung von multipler sklerose ATE279924T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99104793 1999-03-10
PCT/EP2000/001703 WO2000053182A2 (en) 1999-03-10 2000-03-01 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
ATE279924T1 true ATE279924T1 (de) 2004-11-15

Family

ID=8237737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00910736T ATE279924T1 (de) 1999-03-10 2000-03-01 3-cyclopropylmethoxy-4-difluormethoxy-n-(3,5- dichlor-pyrid-4-yl)-benzamid zur behandlung von multipler sklerose

Country Status (12)

Country Link
US (1) US6531493B1 (enExample)
EP (1) EP1161239B1 (enExample)
JP (1) JP2002538207A (enExample)
AT (1) ATE279924T1 (enExample)
AU (1) AU3284000A (enExample)
CA (1) CA2364258C (enExample)
DE (1) DE60015098T2 (enExample)
DK (1) DK1161239T3 (enExample)
ES (1) ES2231162T3 (enExample)
PT (1) PT1161239E (enExample)
SI (1) SI1161239T1 (enExample)
WO (1) WO2000053182A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
WO2002088079A2 (en) * 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
US20030092706A1 (en) * 2001-11-09 2003-05-15 Johannes Barsig Combination
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ES2319517T3 (es) 2002-05-28 2009-05-08 Nycomed Gmbh Preparacion farmaceutica aplicable topicamente.
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
DE102004046235A1 (de) 2004-09-22 2006-03-30 Altana Pharma Ag Arzneimittelzubereitung
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652868B1 (en) 1992-07-28 2004-11-10 Aventis Pharma Limited INHIBITORS OF c-AMP PHOSPHODIESTERASE
HU220041B (hu) 1993-07-02 2001-10-28 Byk Gulden Lomberg Chemische Fabrik Gmbh. Fluor-alkoxi-helyettesített benzamidszármazékok, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyászati készítmények
AU699085B2 (en) * 1994-04-21 1998-11-19 Schering Aktiengesellschaft PDE IV inhibitors for treating Multiple Sclerosis

Also Published As

Publication number Publication date
CA2364258C (en) 2008-12-30
JP2002538207A (ja) 2002-11-12
EP1161239B1 (en) 2004-10-20
AU3284000A (en) 2000-09-28
US6531493B1 (en) 2003-03-11
EP1161239A2 (en) 2001-12-12
DK1161239T3 (da) 2005-02-14
PT1161239E (pt) 2005-02-28
WO2000053182A3 (en) 2001-04-12
WO2000053182A2 (en) 2000-09-14
ES2231162T3 (es) 2005-05-16
DE60015098D1 (de) 2004-11-25
DE60015098T2 (de) 2006-02-02
SI1161239T1 (en) 2005-06-30
CA2364258A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
ATE297917T1 (de) 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen
DK1296671T3 (da) Gabapentinanaloger til sövnforstyrrelser
DE69715861D1 (de) Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression
ATE538096T1 (de) Pyridinon-derivate zur behandlung von arteriosklerose
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE60236218D1 (de) CCR5 Antagonisten verwendbar für die Behandlung von Aids
DE60206164D1 (de) Trisubstituierte-n-((1s)-1,2,3,4-tetrahydro-1-naphthalenyl) benzamide welche p2x3 und p2x2/3 enthaltende rezeptoren inhibieren
IL126110A0 (en) Use of aryl n-substituted carboxamides to kill tumors and novel compounds for such use
ATE279924T1 (de) 3-cyclopropylmethoxy-4-difluormethoxy-n-(3,5- dichlor-pyrid-4-yl)-benzamid zur behandlung von multipler sklerose
DK1404304T3 (da) Tablet omfattende cetirizin og pseudoephedrin
DE69831409D1 (de) Chalcon-derivate mit antiproliferativer aktivität
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
EP1274414A4 (en) NASAL ADMINISTRATION OF AGENTS TO TREAT GASTROPARESIA
DE60104791D1 (de) Cyclobutendion-Derivate zur Behandlung von Artherosclerose
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
HRP20031057B1 (hr) Tableta koja sadrži cetirizin i pseudoefedrin
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
EA200200948A1 (ru) Лечение псориаза
DE69930844D1 (de) Inhibitoren von mycobakterien
ATE345818T1 (de) S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen.
MXPA05010800A (es) Acidos hidroxamicos utiles en el tratamiento de trastornos hiperproliferativos.
DE50302552D1 (de) Verwendung von treosulfan und derivaten davon zur behandlung der multiplen sklerose
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1161239

Country of ref document: EP

EEIH Change in the person of patent owner